Research Article
Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
Table 1
Comparison of patient background characteristic data.
| Characteristic | All patients () | Polypharmacy group () | Nonpolypharmacy group () | value |
| Gender, females , (%) | 70 (48.6) | 29 (60.4) | 41 (42.7) | 0.0450 | Age (y) | 70.9 ± 10.2 | 72.7 ± 10.1 | 70.0 ± 10.2 | 0.1475 | Body mass index (kg/m2) | 21.4 ± 3.8 | 21.8 ± 3.8 | 21.2 ± 3.8 | 0.3895 | Days from stroke onset to admission (d) | 44.3 ± 25.7 | 46.0 ± 18.0 | 43.1 ± 28.7 | 0.4542 | Length of stay (d) | 123.9 ± 46.6 | 123.7 ± 45.2 | 123.9 ± 47.5 | 0.9789 | Number of drugs upon admission | 4.9 ± 2.7 | 7.8 ± 2.2 | 3.4 ± 1.2 | <0.0001 | Number of complications | 3.0 ± 2.0 | 3.8 ± 2.1 | 2.7 ± 1.8 | 0.0011 | Medical history , (%) | | | | | Hypertension | 119 (82.6) | 40 (83.3) | 79 (82.3) | 0.8764 | Diabetes mellitus | 40 (27.8) | 20 (41.7) | 20 (20.8) | 0.0085 | Dyslipidemia | 36 (25.0) | 15 (31.2) | 21 (21.9) | 0.2207 | Cardiovascular disease | 40 (27.8) | 15 (31.3) | 25 (26.0) | 0.5107 | Dementia | 20 (13.9) | 12 (25.0) | 8 (8.3) | 0.0064 | Epilepsy | 16 (11.1) | 7 (14.6) | 9 (9.4) | 0.3485 |
|
|
Mean ± SD.
|